Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma.

Saved in:
Bibliographic Details
Title: Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma.
Authors: Schalm SS; Blueprint Medicines Corporation, Cambridge, Massachusetts., O'Hearn E; Blueprint Medicines Corporation, Cambridge, Massachusetts., Wilson K; Blueprint Medicines Corporation, Cambridge, Massachusetts., LaBranche TP; Blueprint Medicines Corporation, Cambridge, Massachusetts., Silva G; Blueprint Medicines Corporation, Cambridge, Massachusetts., Zhang Z; Blueprint Medicines Corporation, Cambridge, Massachusetts., DiPietro L; Blueprint Medicines Corporation, Cambridge, Massachusetts., Bifulco N; Blueprint Medicines Corporation, Cambridge, Massachusetts., Woessner R; Blueprint Medicines Corporation, Cambridge, Massachusetts., Stransky N; Blueprint Medicines Corporation, Cambridge, Massachusetts., Sappal D; Blueprint Medicines Corporation, Cambridge, Massachusetts., Campbell R; Blueprint Medicines Corporation, Cambridge, Massachusetts., Lobbardi R; Blueprint Medicines Corporation, Cambridge, Massachusetts., Palmer M; Blueprint Medicines Corporation, Cambridge, Massachusetts., Kim J; Blueprint Medicines Corporation, Cambridge, Massachusetts., Ye C; Blueprint Medicines Corporation, Cambridge, Massachusetts., Dorsch M; Blueprint Medicines Corporation, Cambridge, Massachusetts., Lengauer C; Blueprint Medicines Corporation, Cambridge, Massachusetts., Guzi T; Blueprint Medicines Corporation, Cambridge, Massachusetts., Kadambi V; Blueprint Medicines Corporation, Cambridge, Massachusetts., Garner A; Blueprint Medicines Corporation, Cambridge, Massachusetts., Hoeflich KP; Blueprint Medicines Corporation, Cambridge, Massachusetts.
Source: Gastro hep advances [Gastro Hep Adv] 2022 Nov 08; Vol. 2 (3), pp. 307-321. Date of Electronic Publication: 2022 Nov 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc on behalf of the AGA Institute Country of Publication: Netherlands NLM ID: 9918350485906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-5723 (Electronic) Linking ISSN: 27725723 NLM ISO Abbreviation: Gastro Hep Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2772-5723
DOI:10.1016/j.gastha.2022.11.004